{
    "nctId": "NCT01004744",
    "briefTitle": "Pre-Surgical Intervention for Targeted Therapies for Breast Cancer",
    "officialTitle": "Feasibility of Pre-Surgical Intervention Studies for Evaluating Targeted Therapies for Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Invasive Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 10,
    "primaryOutcomeMeasure": "Number of Subjects That Completed Oral Anastrozole 1mg Daily for Two Weeks in the Interval Between Diagnostic Breast Biopsy and Definitive Breast Surgery",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically-confirmed operable ER+ and/or PR+ invasive breast cancer or ductal carcinoma in situ (DCIS), who undergo core needle biopsy followed by surgical excision at least 2 weeks after enrollment\n* Postmenopausal status defined as cessation of menses for \\>1 year or FSH \\> 20 mIU/mL (within the past month)\n* Age \u2265 21 years\n* No prior chemotherapy, radiation therapy, or surgery within 6 months of study entry\n* Signed informed consent\n\nExclusion Criteria:\n\n* Treatment with other investigational drugs within 6 months of study entry\n* Other serious intercurrent medical illness",
    "sex": "FEMALE",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}